Can I Buy ABIOMED Inc Shares in India?

Yes, ABIOMED Inc shares can be bought in India by opening an international trading account with Groww.

How to Buy ABIOMED Inc Shares in India?

One can easily invest in ABIOMED Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ABIOMED Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ABIOMED Inc.

What is the Share Price of ABIOMED Inc?

The share price of ABIOMED Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current ABIOMED Inc share price is $381.02 as of 22 Apr ‘24

What is the Market Cap of ABIOMED Inc?

The ABIOMED Inc market cap is $17.18B as of 22 Apr ‘24

What is the PE and PB ratio of ABIOMED Inc?

The PE and PB ratio of ABIOMED Inc is 64.4 and 11.2 as of 22 Apr ‘24

ABIOMED Inc Share Price, ABMD Stock Price Quote Today

<img alt="ABIOMED Inc" srcSet=" 1x,  2x" src="" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
ABIOMED Inc Healthcare 
$381.02
+0.23(0.06%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$380.78$381.0220,612,2572,131,045
FundamentalsMarket Cap$17.18B
P/B Ratio11.2
P/E Ratio64.4
Enterprise Value$16.99B
Div. Yield0.00%
Book Value33.94
EPS(TTM)2.34
ROENA
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanySince its inception in 1981, Abiomed Inc. has introduced advanced and beneficial technologies for patients and physicians alike. It is a pioneer and global leader in the healthcare industry. The company has its headquarters in Massachusetts, USA, with offices in various locations around the globe, including two in Germany and one in Japan.
Abiomed was founded with a motive to develop the first artificial human heart. The company accomplished this goal and introduced AbioCor, the world’s first completely self-contained, implantable artificial heart. It was successfully transplanted to a patient in 2001. Subsequently, more such transplants were carried out. On September 5th 2006, this device received approval from the Food and Drugs Administration (FDA).
In 2005, the company acquired Impella CardioSystems AG of Germany, maker of Impella – the world’s smallest heart pump. With this acquisition, its focus shifted from heart replacement to recovery. These devices are available in a variety of ranges, with some of them receiving FDA approvals in the US.
Times Magazine awarded AbioCor the Best Invention of the Year award in 2001. The company ranked 64 among the 2000 Global Growth Champions list by Forbes in 2018. It was also added to the S&P 500 index in this same year.
In 2019, Abiomed ranked 19th on the Fortune magazine’s list of 100 fastest-growing companies. It held the 4th position in Barron’s ranking of the best-performing stocks of the 2010s. Furthermore, on 25th March 2020, Abiomed announced its strategies to aid the global medical community and improved patient care during Covid-19 outbreak.
Abiomed Inc. is a leading provider of circulatory support to patients. It engages in research, development and sale of medical devices catering to the care of patients with heart issues. Its products are designed to assist a failing heart, thus improving the blood flow. Over years, Abiomed has remained dedicated in serving the global healthcare community through sincere efforts and a mission of ‘recovering hearts and saving lives’.;
OrganisationABIOMED Inc
IndustryMedical Devices
HeadQuartersDanvers, MA
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Invest the way you want

Join millions of Indians who trust and love Groww

Explore Products

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsIPOMutual FundsCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapIncome Tax Calculator
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$380.78	$381.02	20,612,257	2,131,045

Market Cap	$17.18B
P/B Ratio	11.2
P/E Ratio	64.4
Enterprise Value	$16.99B

Organisation	ABIOMED Inc
Industry	Medical Devices
HeadQuarters	Danvers, MA